⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30414122 | 0.81 | — | — | |
| SCHEMBL9385585 | 0.63 | — | — | |
| SCHEMBL441039 | 0.58 | — | — | |
| SCHEMBL9149173 | 0.57 | — | — | |
| SCHEMBL28647452 | 0.57 | NISCH (0.34) | — | |
| SCHEMBL28835013 | 0.56 | — | — | |
| SCHEMBL29137615 | 0.55 | — | — | |
| SCHEMBL17969241 | 0.52 | — | — | |
| SCHEMBL6480544 | 0.51 | — | — | |
| SCHEMBL9196460 | 0.42 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124144-A1 | COMPOSITIONS COMPRISING DISODIUM LEVOFOLINATE | Acrotech Biopharma Inc. (US) | 2026-05-07 | — | — | US | disclosed |
| US-12564556-B1 | Compositions comprising disodium levofolinate | Acrotech Biopharma Inc. (US) | 2026-03-03 | — | — | US | disclosed |
| US-12539276-B1 | Compositions comprising disodium levofolinate | Acrotech Biopharma Inc. (US) | 2026-02-03 | — | — | US | disclosed |
| US-11541012-B1 | Compositions comprising disodium levofolinate | Acrotech Biopharma, LLC (US) | 2023-01-03 | — | — | US | disclosed |